Julie E. Pickett

1.2k total citations · 1 hit paper
24 papers, 783 citations indexed

About

Julie E. Pickett is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Julie E. Pickett has authored 24 papers receiving a total of 783 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 5 papers in Organic Chemistry and 5 papers in Oncology. Recurrent topics in Julie E. Pickett's work include Orthopedic Infections and Treatments (4 papers), Chemical Synthesis and Analysis (3 papers) and Microtubule and mitosis dynamics (3 papers). Julie E. Pickett is often cited by papers focused on Orthopedic Infections and Treatments (4 papers), Chemical Synthesis and Analysis (3 papers) and Microtubule and mitosis dynamics (3 papers). Julie E. Pickett collaborates with scholars based in United States, Germany and United Kingdom. Julie E. Pickett's co-authors include Daniel L.J. Thorek, Carrow I. Wells, David H. Drewry, Bryan L. Roth, Fei Tong, Arman A. Sadybekov, Yurii S. Moroz, Vsevolod Katritch, Manish K. Jain and Yongfeng Liu and has published in prestigious journals such as Nature, Nature Communications and Journal of Medicinal Chemistry.

In The Last Decade

Julie E. Pickett

24 papers receiving 775 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Synthon-based ligand discovery in virtual libraries of over 11 billion compounds

2021 254 citations Arman A. Sadybekov, Anastasiia Sadybekov et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julie E. Pickett United States	14	475	172	112	83	69	24	783
Qiaodan Zhou China	10	535 1.1×	105 0.6×	132 1.2×	72 0.9×	64 0.9×	21	815
Carrow I. Wells United States	18	566 1.2×	109 0.6×	187 1.7×	132 1.6×	25 0.4×	46	843
István Hajdú Hungary	14	371 0.8×	76 0.4×	126 1.1×	61 0.7×	32 0.5×	34	673
Gregg Timony United States	11	545 1.1×	67 0.4×	73 0.7×	107 1.3×	45 0.7×	24	882
Kevin R. Kupcho United States	10	481 1.0×	40 0.2×	104 0.9×	80 1.0×	20 0.3×	22	707
Nicodème Paul France	17	628 1.3×	158 0.9×	118 1.1×	30 0.4×	27 0.4×	30	953
Brian B. Haines United States	17	948 2.0×	196 1.1×	322 2.9×	69 0.8×	17 0.2×	39	1.4k
Eric S. Day United States	16	766 1.6×	86 0.5×	202 1.8×	94 1.1×	40 0.6×	25	1.4k
Erica L. Bradshaw‐Pierce United States	19	577 1.2×	60 0.3×	288 2.6×	52 0.6×	33 0.5×	25	982
Daniel J. Burdick United States	13	353 0.7×	57 0.3×	77 0.7×	96 1.2×	83 1.2×	19	613

Countries citing papers authored by Julie E. Pickett

Since Specialization

Citations

This map shows the geographic impact of Julie E. Pickett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie E. Pickett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie E. Pickett more than expected).

Fields of papers citing papers by Julie E. Pickett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie E. Pickett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie E. Pickett. The network helps show where Julie E. Pickett may publish in the future.

Co-authorship network of co-authors of Julie E. Pickett

This figure shows the co-authorship network connecting the top 25 collaborators of Julie E. Pickett. A scholar is included among the top collaborators of Julie E. Pickett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie E. Pickett. Julie E. Pickett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sadybekov, Anastasiia, Saheem A. Zaidi, Dmitry B. Eremin, et al.. (2024). Virtual Screening of a Chemically Diverse “Superscaffold” Library Enables Ligand Discovery for a Key GPCR Target. ACS Chemical Biology. 19(4). 866–874. 5 indexed citations

Chiu, Yi-Ting, et al.. (2023). Illuminating the understudied GPCR-ome. Drug Discovery Today. 29(3). 103848–103848. 6 indexed citations

Dhaynaut, Maëva, Nicolas J. Guehl, Sepideh Afshar, et al.. (2022). Design, Synthesis, and Characterization of [ ¹⁸ F]mG2P026 as a High-Contrast PET Imaging Ligand for Metabotropic Glutamate Receptor 2. Journal of Medicinal Chemistry. 65(14). 9939–9954. 7 indexed citations

Dhaynaut, Maëva, Yu Lan, Nicolas J. Guehl, et al.. (2022). Synthesis and Characterization of 5-(2-Fluoro-4-[ ¹¹ C]methoxyphenyl)-2,2-dimethyl-3,4-dihydro-2 H -pyrano[2,3- b ]pyridine-7-carboxamide as a PET Imaging Ligand for Metabotropic Glutamate Receptor 2. Journal of Medicinal Chemistry. 65(3). 2593–2609. 4 indexed citations

Asquith, Christopher R. M., Michael P. East, Tuomo Laitinen, et al.. (2022). Identification of 4‐Anilinoquin(az)oline as a Cell‐Active Protein Kinase Novel 3 (PKN3) Inhibitor Chemotype**. ChemMedChem. 17(12). e202200161–e202200161. 3 indexed citations

Wells, Carrow I., Julie E. Pickett, Lauren E. Howard, et al.. (2021). Non-canonical role of Hippo tumor suppressor serine/threonine kinase 3 STK3 in prostate cancer. Molecular Therapy. 30(1). 485–500. 23 indexed citations

Pickett, Julie E., et al.. (2021). Estimating the prevalence of heterochromia iridum from high-resolution digital yearbook portraits. Journal of Optometry. 15(3). 248–250. 1 indexed citations

Thompson, John M., Alyssa G. Ashbaugh, Yu Wang, et al.. (2021). Predilection for developing a hematogenous orthopaedic implant-associated infection in older versus younger mice. Journal of Orthopaedic Surgery and Research. 16(1). 556–556. 2 indexed citations

Wells, Carrow I., David H. Drewry, Julie E. Pickett, et al.. (2021). Development of a potent and selective chemical probe for the pleiotropic kinase CK2. Cell chemical biology. 28(4). 546–558.e10. 68 indexed citations

10.

Sadybekov, Arman A., Anastasiia Sadybekov, Yongfeng Liu, et al.. (2021). Synthon-based ligand discovery in virtual libraries of over 11 billion compounds. Nature. 601(7893). 452–459. 254 indexed citations breakdown →

11.

Lorente‐Macías, Álvaro, et al.. (2020). Towards a RIOK2 chemical probe: cellular potency improvement of a selective 2-(acylamino)pyridine series. RSC Medicinal Chemistry. 12(1). 129–136. 4 indexed citations

12.

Wells, Carrow I., James D. Vasta, Cesear Corona, et al.. (2020). Quantifying CDK inhibitor selectivity in live cells. Nature Communications. 11(1). 2743–2743. 78 indexed citations

13.

Wells, Carrow I., Rafael M. Couñago, Juanita C. Limas, et al.. (2019). SGC-AAK1-1: A Chemical Probe Targeting AAK1 and BMP2K. ACS Medicinal Chemistry Letters. 11(3). 340–345. 28 indexed citations

14.

Asquith, Christopher R. M., James M. Bennett, Tuomo Laitinen, et al.. (2019). Towards the Development of an In vivo Chemical Probe for Cyclin G Associated Kinase (GAK). Molecules. 24(22). 4016–4016. 15 indexed citations

15.

Pickett, Julie E., John M. Thompson, Agnieszka Sadowska, et al.. (2018). Molecularly specific detection of bacterial lipoteichoic acid for diagnosis of prosthetic joint infection of the bone. Bone Research. 6(1). 13–13. 29 indexed citations

16.

Thompson, John M., Robert J. Miller, Alyssa G. Ashbaugh, et al.. (2018). Mouse model of Gram-negative prosthetic joint infection reveals therapeutic targets. JCI Insight. 3(17). 27 indexed citations

17.

Kim, Soohyun P., Zhu Li, Julie L. Frey, et al.. (2017). Fatty acid oxidation by the osteoblast is required for normal bone acquisition in a sex- and diet-dependent manner. JCI Insight. 2(16). 108 indexed citations

18.

Abou, Diane S., Julie E. Pickett, & Daniel L.J. Thorek. (2015). Nuclear molecular imaging with nanoparticles: radiochemistry, applications and translation. British Journal of Radiology. 88(1054). 20150185–20150185. 28 indexed citations

19.

Pickett, Julie E., András Váradi, Travis C. Palmer, et al.. (2015). Mild, Pd-catalyzed stannylation of radioiodination targets. Bioorganic & Medicinal Chemistry Letters. 25(8). 1761–1764. 14 indexed citations

20.

Pickett, Julie E., et al.. (2013). Sandmeyer reaction repurposed for the site-selective, non-oxidizing radioiodination of fully-deprotected peptides: Studies on the endogenous opioid peptide α-neoendorphin. Bioorganic & Medicinal Chemistry Letters. 23(15). 4347–4350. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact